1. Deb AK, Kaliaperumal S, Rao VA, Sengupta S. Relationship between systemic hypertension, perfusion pressure and glaucoma: a comparative study in an adult Indian population. Indian J Ophthalmol. 2014;62(9):917–922. doi:10.4103/0301–4738.143927
2. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126(4):513–518.
3. Шишкин А. И., Лындина М. Л. Эндотелиальная дисфункция и артериальная гипертензия. Артериальная гипертензия. 2008;14(4):315–319..
4. Choi J, Kook MS. Systemic and ocular hemodynamic risk factors in glaucoma. Biomed Res Int. 2015;2015:141905. doi:10. 1155/2015/141905
5. Hayreh H. Blood flow in optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595–624.
6. Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. American Journal of Ophthalmology. 2010;149(5): 704–712.
7. Fan N, Wang P, Tang L, Liu X. Ocular blood flow and normal tension glaucoma. Biomed Research International. 2015:2015:308505. doi:10.1155/2015/308505
8. Flammer J. The glaucomatous optic neuropathy: a re-perfusion damage. Klinische Monatsblatter fur Augenheilkunde. 2001;218(5):290–291.
9. Choi J, Jeong J, Cho HS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol. 2004;48(4):380–385.
10. Graham SL, Drance SM. Nocturnal hypotension: Role in glaucoma progression. Surv Ophthalmol. 1999;43(Suppl 1): S10–6.
11. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS. Ambulatory blood pressure monitoring in glaucoma. Ophthalmology. 1995;102(1):61–69.
12. Акопов Е. Л., Астахов Ю. С., Нефедова Д. М. Сосудистые факторы риска развития первичной открытоугольной глаукомы. Клин. офтальмол. 2008;2:68–71..
13. Астахов Ю. С., Гозиев С. Д., Шихалиев Д. Р. Влияние нефиксированной и фиксированной комбинации 0,5 % тимолола и 0,005 % латанопроста на местную и системную гемодинамику при лечении пациентов с ПОУГ. Офтальмологические ведомости. 2009;2(1):12–17..
14. Астахов Ю. С., Устинова Е. И., Катинас Г. С., Устинов С. Н., Байгушева С. С. О традиционных и современных способах исследования колебаний офтальмотонуса. Офтальмологические ведомости. 2008;1(2):7–12..
15. Matsui Y, Eguchi K, Ishikawa J, Hoshide S, Shimada K, Kario K et al. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement. Am J Hypertens. 2007;20 (4):385–391.
16. White WB. The night-time might be the right time for cardiovascular event prediction. Hypertension. 2012;60(1):8–9.
17. Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the night-time blood pressure. Hypertension. 2011;57(1):3–10.
18. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131(8):564–572.
19. Rosa AA, Ortega KC, Mion DJ, Nakashima Y. Prevalence of arterial hypertension in branch retinal vein occlusion patients. Arq Bras Oftalmol. 2008;71(2):162–166.
20. Rao VN, Ulrich JK, Viera AJ, Parlin A, Fekrat S, Chavala SH. Ambulatory blood pressure patterns in patients with retinal vein occlusion. Ophthalmic Communications Society. 2016; 36(12):2304–2310.
21. Park SJ, Moon SW, Lim SH, Yoon IH, Choi KN, Lee HY. Diurnal blood pressure variation in the retinal vein occlusion. J Korean Ophthalmol Soc. 2013;54(9):1371–1378. doi:10.3341/ jkos.2014.54.9.1371
22. Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A et al. Flammer Syndrome. The EPMA J. 2014:5(1):11.
23. Тульцева С. Н., Титаренко А. И., Руховец А. Г. Ха-рактеристика системной и регионарной гемодинамики при ишемической окклюзии вен сетчатки у лиц молодого и среднего возраста. Регионарное кровообращение и микроциркуляция. 2016;2(58):24–31..
24. Koseki N, Araie M, Tomidokoro A, Nagahara M, Hasegawa T, Tamaki Y et al. A placebo-controlled 3 year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology. 2008;115(11):2049–2057.
25. Pesin N, Mandelcorn ED, Felfeli T, Ogilvie RI, Brent MH. The role of occult hypertension in retinal vein occlusions and diabetic retinopathy. Can J Ophthalmol. 2016;1:1–3. http://dx.doi. org/10.1016/j.jcjo.2016.09.009
26. Hayreh SS, Zimmerman B, Mccarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Elsevier Science Inc. 2001;131(1):61–77.
27. Sinawat S, Bunyavee C, Ratanapakorn T, Sinawat S, Laovirojjanakul W, Yospaiboon Y. Systemic abnormalities associated with retinal vein occlusion in young patients. Clinical Ophthalmology. 2017;11:441–447. doi:10.2147/OPTH.S128341.
28. O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126(5):692–699.
29. Werther W, Chu L, Holekamp N, Do DV, Rubio RG. Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol. 2001;129(3):326–331.
30. Lee J, Choi J, Jeong D, Kim S, Kook MS. Relationship between daytime variability of blood pressure or ocular perfusion pressure and glaucomatous visual field progression. Am J Ophthalmol. 2015;160(3):522–537.
31. Ho JD, Liou SW, Lin HC. Retinal vein occlusion and the risk of stroke development: a five-year follow-up study. Am J Ophthalmol. 2009;147(2):283–290.
32. Tsaloumas MD, Kirwan J, Vinall H, O’Leary MB, Prior P, Kritzinger EE et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye (Lond). 2000;14(Pt 6): 821–827.
33. Hu C, Ho J, Lin H. Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol. 2009;93(6):717–720.
34. Mansour A, Walsh J, Henkind P. Mortality and morbidity in patients with central retinal vein occlusion. Ophthalmologica. 1992;204(4):199–203.
35. Park SJ, Choi NK, Yang BR, Park KH, Woo SJ. Risk of stroke in retinal vein occlusion. Neurology. 2015;85(18):1578– 1584.
36. Bertelsen M, Linneberg A, Christoffersen N, Vorum H, Gade E, Larsen M. Mortality in patients with central retinal occlusion. Ophthalmology. 2014;121(3):637–642.
37. Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4(1):14.
38. Fraenkl SA, Mozaffarieh M, Flammer J. Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J. 2010;1(2):253–261.
39. Tanano I, Nagaoka T, Sogawa K, Tani T, Omae T, Nakabayashi S et al. Impaired systemic vascular endothelial function in patients with branch retinal vein occlusion. Curr Eye Res. 2013;38(1):114–118.
40. Hollo G. Plasma endothelial-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol. 1999;83(1):127–128.
41. Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:1–12. doi:10.1186/s13167– 015–0043–1.
42. McAlister I, Tan M, Smithies L, Wong WL. The Effect of Central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion. Am Acad Ophthalmol. 2014;121(11):2228–2236.
43. Малишевская Т. Н., Астахов С. Ю. Реактивность сосудистого эндотелия у пожилых пациентов с первичной открытоугольной глаукомой и физиологически стареющих людей в зависимости от выраженности эндотелиальной дисфункции. Регионарное кровообращение и микроциркуляция. 2016;15(4): 59–67..
44. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retina Eye Res. 2008;27(6):622–647.